Judges Hold the Line on Gene Patents – Wall Street Journal
The U.S. Court of Appeals for the Federal Circuit was revisiting its 2-1 ruling last July that largely upheld Myriad Genetics Inc.’s patents on two genes that can signal if a woman faces greater risk of developing breast cancer or ovarian cancer.
Subscribe to LegalLaw247.Com Newsletter
